Larimar Therapeutics Inc.

NASDAQ: LRMR · Real-Time Price · USD
3.98
-0.28 (-6.57%)
At close: Aug 15, 2025, 2:59 PM

Larimar Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
33.22M 26.75M 26.82M 70.1M
Short-Term Investments
150.24M 60.04M 91.6M n/a
Long-Term Investments
n/a 1.34M 1.34M 1.34M
Other Long-Term Assets
1.2M 659K 638K 669K
Receivables
n/a n/a n/a 208K
Inventory
n/a n/a n/a -208K
Other Current Assets
517K 709K n/a 279K
Total Current Assets
195.3M 90.17M 120.74M 72.2M
Property-Plant & Equipment
3.72M 3.76M 3.69M 4.46M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
4.92M 5.76M 5.67M 6.46M
Total Assets
200.22M 95.94M 126.41M 78.67M
Account Payables
2.42M 1.28M 1.69M 1.66M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
1.06M n/a 611K 594K
Other Current Liabilities
20.87M n/a 5.75M 4.9M
Total Current Liabilities
24.36M 9.51M 10.71M 8.85M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
4.06M 4.71M 4.8M 5.41M
Total Liabilities
28.41M 14.21M 15.5M 14.25M
Total Debt
5.12M 5.55M 5.41M 6M
Common Stock
64K 43K 43K 18K
Retained Earnings
-269.16M -188.55M -151.6M -116.25M
Comprehensive Income
n/a 81K -31K -0.00
Shareholders Equity
171.81M 81.72M 110.9M 64.41M
Total Investments
150.24M 61.38M 91.6M 1.34M